|
Volumn 61, Issue 6, 2001, Pages 685-694
|
Enzymatic activation of a new antitumour drug, 5-diethylaminoethylamino-8-hydroxyimidazoacridinone, C-1311, observed after its intercalation into DNA
|
Author keywords
Antitumour compounds; DNA intercalation; Enzymatic activation; Imidazoacridinone derivatives; Metabolic activation; Mode of antitumour action
|
Indexed keywords
DNA;
HORSERADISH PEROXIDASE;
HYDROGEN PEROXIDE;
IMIDACRINE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CELL FREE SYSTEM;
COVALENT BOND;
DRUG ACTIVATION;
DRUG DNA INTERACTION;
DRUG OXIDATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
INTERCALATION COMPLEX;
MASS SPECTROMETRY;
METABOLIC ACTIVATION;
PRIORITY JOURNAL;
ULTRAVIOLET SPECTROSCOPY;
AMINOACRIDINES;
ANTINEOPLASTIC AGENTS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DNA, VIRAL;
HORSERADISH PEROXIDASE;
HYDROGEN PEROXIDE;
OXIDATION-REDUCTION;
PRODRUGS;
SIMIAN VIRUS 40;
SPECTROPHOTOMETRY, ULTRAVIOLET;
|
EID: 0035868981
PISSN: 00062952
EISSN: None
Source Type: Journal
DOI: 10.1016/S0006-2952(01)00527-5 Document Type: Article |
Times cited : (35)
|
References (17)
|